Exploring the hair loss risk in glucagon-like peptide-1 agonists: emerging concerns and clinical implications
PMID: 27847966 | doi:10.1007/s00109-016-1488-y Seiwerth S et al
Not sure whether to choose an IV, push, or shot
W., and Li, S
Tip: Use morning and evening for best results
Were getting a lot of questions [from CPG clients], with interest peaking after the comments from Walmart, so we started to look at some of the studies that we were conducting to see if we could add some questions for people taking these GLP-1 drugs. As for Hartmans clients, she says, food and beverage companies have already been steadily cutting sugar from beverages, and reducing sugar, saturated fat, and sodium from many of their foods, so in many respects, GLP-1 drugs may just accelerate this trend